Compumedics Limited (AU:CMP) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Compumedics Limited has reported a remarkable 136% increase in sales orders in its USA market, driven by the success of its sleep and Somfit business, with Somfit sales nearing $1 million. In Europe, the company secured a significant contract in Poland, further strengthening its position in the region. Compumedics continues to build momentum in both markets, reaffirming its sales growth strategy for FY25.
For further insights into AU:CMP stock, check out TipRanks’ Stock Analysis page.